Articles from Inspection Monitor (October 1, 1998)

Title	Author	Type	Words
Bayer audit hits plasma, albumin, lyophilization.		Brief Article	904
FDA urges product-specific studies, looks at ISO rules.			960
Haimen rebounds from allegations, violations.		Brief Article	590
INSPECTION LOG.		Brief Article	714
MDRs point FDA to look at Mallinckrodt plants.		Brief Article	644
More BiMo audits seen if Henney gets FDA post.		Brief Article	598
Needle complaints lead to 483, warning letter.			1008
NeXstar gets two 483s, advice, but no warnings.		Brief Article	883
No new warning letters follow 483s to state lab.			1178
Preapproval audit yields advice, no 483 to Perrigo.		Brief Article	789
Time constraints, DCIS restrict foreign audit.		Brief Article	573